#ACR21 Abs#1428. Retrospective cohort VA study ▶️45% of patients got >30 days of GC use in a 6-month period - high # of pts! ▶️3% MACE events during study period ⭐️30 days of glucocorticoids = 15%⬆️ in odds of MACE in RA pts! @Rheumnow https://t.co/m5bl9Ho163 https://t.co/v8hdzi1Vrb